Get the Daily Brief

All action, no filler. BioBriefs delivers the industry’s 10 must-know updates, every morning.

Latest Biotech News

AI agents and probes accelerate cancer research workflows

January 19, 2026

Industry pieces and lab reports show AI agents and tailored deep‑learning tools are moving from data curation to active roles in cancer research. One analysis outlined how autonomous AI agents are...

Sarepta misses Elevidys targets — stock tumbles

January 19, 2026

Sarepta reported preliminary Q4 2025 results showing Elevidys revenue fell to $110.4 million, down 17% from the prior quarter, and below analyst expectations. The disclosure triggered an investor...

NIH FY2026 showdown: preserve $48.7B

January 19, 2026

Advocates are urging U.S. House members to support a FY2026 appropriations bill that keeps NIH funding at the Senate-approved $48.7 billion and preserves Senate language on indirect-cost caps and...

Legal doubts swirl over FDA’s new expedited program

January 19, 2026

Reporting has surfaced that senior FDA leaders and staff have expressed concerns about a newly implemented expedited drug program, including who should sign final approvals and whether normal...

Unedited CD7 CAR‑T shows promise in T‑cell leukemia

January 19, 2026

A study published in the Journal of Translational Medicine reports that fratricide-driven, unedited CD7 CAR‑T cells demonstrate anti-leukemia activity against T‑cell malignancies. Researchers...

TGFβ-driven shape shift lets dormant cancer hide — MSK

January 19, 2026

Researchers at Memorial Sloan Kettering Cancer Center reported in Nature Cancer that disseminated lung adenocarcinoma cells enter a TGFβ-induced, atypical epithelial-to-mesenchymal transition that...

Whole-transcriptome diagnostics scaled to 1,233 FFPE tumors

January 19, 2026

A study in the British Journal of Cancer presents diagnostic whole-transcriptome sequencing applied to 1,233 formalin-fixed paraffin-embedded (FFPE) solid tumor samples, demonstrating feasibility...

Real-time metabolic monitoring tightens CGT manufacturing control

January 19, 2026

PHCNA’s Tia Harmon highlighted technologies for real-time metabolic monitoring that give manufacturers earlier insight into cell behavior during complex cell and gene therapy (CGT) workflows. The...

AI redesigns antibodies into live-cell reporters — Colorado State

January 19, 2026

Researchers at Colorado State University described an AI-driven workflow to modify antibodies so they act as intracellular fluorescent probes, enabling visualization of specific protein activities...

Enterococcus redox metabolism blocks wound healing — target found

January 19, 2026

An NTU Singapore and University of Geneva team published in Science Advances that Enterococcus faecalis deploys extracellular electron transport (EET) to generate reactive oxygen species,...

Targeting innate immunity: cGAS–STING mapped — MERTK inhibitor disrupts efferocytosis

January 19, 2026

Two complementary reports highlight innate-immune targets shaping cancer immunity and inflammation. A review of the cGAS–STING pathway synthesizes opportunities and challenges for cancer therapy,...

Sarepta’s Elevidys shortfall — CEO defends sales as stock slips

January 19, 2026

Sarepta Therapeutics reported preliminary Q4 2025 results showing Elevidys (delandistrogene moxeparvovec-rokl) sales of $110.4 million, a quarter-on-quarter decline that missed analyst forecasts...

FDA backs Hemostemix basket approach — regulator signals support

January 19, 2026

Hemostemix received FDA support for its basket protocol approach, a regulatory milestone the company says will streamline the development of its platform across multiple indications. The...

FDA expedited approvals under fire: who will sign off?

January 19, 2026

Reporting has surfaced internal legal and procedural questions around the FDA’s new expedited drug program, including who within the agency is willing to sign final approvals and whether standard...

NIH FY2026 at stake: advocates urge House to preserve $48.7B

January 19, 2026

Advocates are calling on House appropriators to adopt the Senate-approved FY2026 NIH funding level of $48.7 billion and to retain Senate language protecting indirect cost policies and multi‑year...

Real-time metabolic monitoring: deeper control for cell and gene therapy

January 19, 2026

Industry voices including Tia Harmon at PHCNA are spotlighting real‑time metabolic monitoring technologies that deliver earlier intervention points in complex cell and gene therapy (CGT)...

AI agents move into oncology labs — from classification to decision-making

January 19, 2026

Researchers and companies are accelerating deployment of AI agents that go beyond classification to assist experimental design, hypothesis generation, and therapeutic decision pathways in...

Dormant metastases go soft — MSK shows shape‑shift shields cells from immunity

January 19, 2026

Memorial Sloan Kettering researchers report in Nature Cancer that disseminated cancer cells can enter a TGFβ‑driven program that ultimately transitions cells into a round, low‑tension morphology,...

E. faecalis redox metabolism impairs healing — study points to new therapies

January 19, 2026

An international team led by NTU Singapore and the University of Geneva reports in Science Advances that Enterococcus faecalis uses extracellular electron transport (EET) to generate reactive...

Unedited CD7 CAR‑Ts beat T‑cell leukemia in preclinical tests — fratricide exploited

January 19, 2026

A study in the Journal of Translational Medicine describes a fratricide‑driven strategy using unedited CD7 CAR‑T cells to treat T‑cell acute lymphoblastic leukemia. Rather than genetically...